-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Evofem Biosciences, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2021 to Q3 2024.
- Evofem Biosciences, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $6.94M, a 19.9% decline year-over-year.
- Evofem Biosciences, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $27.2M, a 32.3% decline year-over-year.
- Evofem Biosciences, Inc. annual Costs and Expenses for 2023 was $36.1M, a 64.3% decline from 2022.
- Evofem Biosciences, Inc. annual Costs and Expenses for 2022 was $101M, a 42.3% decline from 2021.
- Evofem Biosciences, Inc. annual Costs and Expenses for 2021 was $175M, a 68.2% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)